Actively Recruiting
Responders and Non-responders in the Management of Heart Failure - Significance of Genetic Influence and Identification of Novel Informative Biomarkers
Led by Karolinska University Hospital · Updated on 2024-05-30
5000
Participants Needed
1
Research Sites
514 weeks
Total Duration
On this page
Sponsors
K
Karolinska University Hospital
Lead Sponsor
U
University Hospital, Linkoeping
Collaborating Sponsor
AI-Summary
What this Trial Is About
A biobank within the Swedish national heart failure quality registry SwedeHF.
CONDITIONS
Official Title
Responders and Non-responders in the Management of Heart Failure - Significance of Genetic Influence and Identification of Novel Informative Biomarkers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provided written informed consent
- Diagnosed with heart failure based on symptoms and signs as judged by a local investigator
- Registered in the Swedish national heart failure quality registry (SwedeHF)
You will not qualify if you...
- Donated plasma within 1 month before enrollment or lost more than 500 mL of blood within 3 months before enrollment
- Had a previous allogeneic bone marrow transplant
- Any condition that the investigator believes could put the patient at risk, affect study results, or hinder participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Karolinska University hospital
Stockholm, Sweden, 17164
Actively Recruiting
Research Team
C
Camilla Hage, Ass prof
CONTACT
U
Ulf Dahlström, Prof
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here